Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of BioAtla (NASDAQ:BCAB) through any online brokerage.
There are no as such competitors for BioAtla.
BioAtla has a consensus price target of $11.25.
The stock price for BioAtla (NASDAQ: BCAB) is $4.0203 last updated July 15, 2026 at 2:01 PM EDT.
There are no upcoming dividends for BioAtla.
BioAtla does not have any upcoming earnings scheduled.
There is no upcoming split for BioAtla.
BioAtla is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.